NCT04256824

Triclosan-antibacterial Sutures Efficacy on the Incidence of Surgical Site Infection in Clean-contaminated Wounds

Triclosan-antibacterial Sutures Efficacy on the Incidence of Surgical Site Infection in Clean-contaminated Wounds; Multi-center, Double Blind, Randomized Study

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 430 (estimated)
• Sponsor: ClinAmygate · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Comparing the incidence of SSI in cases using coated Polyglactin 910 suture with Triclosan and cases using Polyglactin 910 suture without Triclosan in clean-contaminated wound surgery

Detailed description

Comparing the incidence of surgical site infection (SSI) in cases using coated Polyglactin 910 suture with Triclosan and cases using Polyglactin 910 suture without Triclosan in clean-contaminated wound surgery. Also, comparing the post hospital stay.

Conditions

• Surgical Site Infection
• Surgical Wound
• Surgical Wound Infection

Interventions

Type	Name	Description
DRUG	coated vicryl plus	Coated Polyglactin 910 with Triclosan (coated vicryl plus)
DRUG	Vicryl	Coated Polyglactin 910 without Triclosan (vicryl)

Timeline

• Start date: 2020-02-05
• Primary completion: 2023-10-10
• Completion: 2024-01-30
• First posted: 2020-02-05
• Last updated: 2023-09-06

Locations

1 site across 1 country: Egypt

Regulatory

• FDA-regulated drug study